{"url":"https://lda.senate.gov/api/v1/filings/75186a3e-8599-4eb2-bc33-2e37eee147ca/","filing_uuid":"75186a3e-8599-4eb2-bc33-2e37eee147ca","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/75186a3e-8599-4eb2-bc33-2e37eee147ca/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Wade Ackerman","dt_posted":"2022-04-20T17:45:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 10th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.senate.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":212038,"url":"https://lda.senate.gov/api/v1/clients/212038/","client_id":1006512,"name":"RWE ALLIANCE INC.","general_description":"Real-world data and analytics organizations","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Food and Drug Administration policies on real-world data and evidence in regulatory decision making; Cures 2.0 Act (H.R. 6000); PREVENT Pandemics Act (S. 3799).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70660,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"SCHREURS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Food and Drug Administration policies on real-world data and evidence in regulatory decision making; Cures 2.0 Act (H.R. 6000); PREVENT Pandemics Act (S. 3799).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70660,"prefix":null,"prefix_display":null,"first_name":"MORGAN","nickname":null,"middle_name":null,"last_name":"SCHREURS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}